The Innate Killer Summit 2017 is dedicated to help you take critical steps to enhance your biological understanding, ensure successful translation and effective clinical development of natural killer, NKT & γδ T cell immunotherapies.

Access exclusive, cutting-edge data and the latest clinical progress needed to implement a best practice approach to progress your natural killer, NKT & γδT cell pipeline with a forward-looking plan for global manufacture and distribution to patients in need. Capitalize on more robust allogeneic development approaches and overcome safety concerns experienced by other cell therapies.